Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|October 18, 2003
Aging and the hemopoietic systemAntonio Pinto, Rosaria De Filippi, Ferdinando Frigeri, et al.
Haematologica|March 9, 2005
Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomasGaetano Corazzelli, Gaetana Capobianco, Filippo Russo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 2, 2016
Richter Syndrome With Plasmablastic Lymphoma at Primary Diagnosis: A Case Report With a Review of the LiteratureAndrea Ronchi, Laura Marra, Ferdinando Frigeri, et al.
Clinical Chemistry and Laboratory Medicine|March 3, 2010
Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnosticsRaffaele Di Francia, Ferdinando Frigeri, Massimiliano Berretta, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2026
Burden and management of infectious diseases in patients treated by chimeric antigen-receptor T (CAR-T)-cell therapy for refractory or relapsing diffuse large B-cell lymphoma or multiple myelomaMariantonietta Pisaturo, Pierantonio Grimaldi, Martina Di Palma, et al.
Hepatitis Monthly|October 31, 2013
Mortality trend for tumor correlated immune system in hyperendemic area of HCV infection in southern Italy: joinpoint analysisMaurizio Montella, Matteo Malvezzi, Maria Grimaldi, et al.
The Journal of Applied Laboratory Medicine|May 15, 2020
Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant DetectionRaffaele Di Francia, Stefania Crisci, Tommaso Muto, et al.
Current Cancer Drug Targets|February 11, 2017
Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted TherapyRaffaele Di Francia, Angela De Monaco, Mariangela Saggese, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphomaGaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone, et al.
Hemasphere|May 26, 2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert PanelPier Luigi Zinzani, Marco Paulli, Luca Arcaini, et al.
Pageof 4